AngioDynamics Reports Fiscal Year 2022 Fourth Quarter and Full-Year Financial Results; Issues Fiscal Year 2023 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. SPY
3. ABBV
4. META
5. FDX
6. IBM
7. NKE
8. MU
9. PFE
10. AWK

Go back to AngioDynamics Reports Fiscal Year 2022 Fourth Quarter and Full-Year Financial Results; Issues Fiscal Year 2023 Guidance

AngioDynamics (ANGO) Reports In-Line Q4 EPS, Offers Guidance

July 12, 2022 7:05 AM EDT

AngioDynamics (NASDAQ: ANGO) reported Q4 EPS of $0.01, in-line with the analyst estimate of $0.01. Revenue for the quarter came in at $87 million versus the consensus estimate of $82.92 million.

GUIDANCE:

AngioDynamics sees FY2023 EPS of $0.01-$0.06, versus the consensus of $0.08. AngioDynamics sees... More